Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FRN93
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,527
Award facts
- Contract value 100% obligated
- $2,527.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $2,527.44 to AmerisourceBergen Drug Corp for HEPLISAV-B vaccine (20 mcg/0.5 mL syringe) on July 21, 2025, with completion scheduled for July 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, reflecting the company's role as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order exemplifies AmerisourceBergen's extensive portfolio of federal vaccine and pharmaceutical supply contracts with the Defense Logistics Agency. The contract carries no set-aside designation and was awarded through open competition, consistent with the company's track record of fulfilling federal medical supply requirements. HEPLISAV-B is a recombinant hepatitis B vaccine indicated for adult immunization, and its procurement through DLA ensures availability for military personnel and beneficiaries within the Defense Health Agency system. AmerisourceBergen's comprehensive IDC vehicle enables flexible, on-demand delivery of pharmaceutical products and medical supplies across multiple therapeutic domains to support global military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FRN93?
SPE2DB25FRN93 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 21, 2025.
How much is contract SPE2DB25FRN93 worth?
The government has obligated $2,527 on SPE2DB25FRN93.
Is contract SPE2DB25FRN93 an order under another contract?
Yes. SPE2DB25FRN93 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRN93 competed?
The extent of competition for SPE2DB25FRN93 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award